Target : Evaluate the consequences of commuting from prasugrel to clopidogrel on platelet inhibition and the clinical results after acute myocardial infarction

Trial date : 2012

Number of patients : 300

Source of funding : Public (INSERM) et private (ACTION group)

Centers participating : Single center (Pitié-Salpêtrière)

STATUS

Publication in JACC – feb 2013